Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F07%3A1625" target="_blank" >RIV/00216208:11130/07:1625 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/07:1625
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia
Original language description
Background. The level of minimal residual disease (MRD) prior to allogeneic hematopoietic stem cell transplantation (HSCT) has been shown to be an independent prognostic factor for outcome of pediatric patients with high-risk acute lymphoblastic leukemia
Czech name
Detekovatelná residuální nemoc před transplantací určuje špatnou prognosu u dětí ALL
Czech description
Detekovatelná residuální nemoc před transplantací určuje špatnou prognosu u dětí ALL

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
<a href="/en/project/NE6929" target="_blank" >NE6929: Early treatment response as the most important prognostic factor in childhood acute lymphoblastic leukemia in the new international treatment protocol</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year
2007
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Result description